P240029/S002: CGuard Prime Carotid Stent System
FDA’s recorded scope: the introduction of an additional stent crimper
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 2 FDA records to the applicant name InspireMD, Ltd.. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Feb 20, 2026 to Mar 16, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code NIM appears in 2 of the 2 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P240029, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 6303 Waterford District Dr., Suite 215, Miami, FL, 33126. Recorded on P240029/S002, decision dated Mar 16, 2026.
FDA’s recorded scope: the introduction of an additional stent crimper
FDA’s recorded scope: modification of the routine sterilization load
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CGuard Prime Carotid Stent SystemP240029/S002 | InspireMD, Ltd. | PMA supplement | Mar 16, 2026 | FDA |
CGuard Prime Carotid Stent SystemP240029/S001 | InspireMD, Ltd. | PMA supplement | Feb 20, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.